A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 625-637

  Izmirli, Muzeyyen ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

A1298C polymorphism; C677T polymorphism; Cancer; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

BREAST CANCER; CANCER RISK; CHROMOSOME 1; DIGESTIVE SYSTEM CANCER; DNA POLYMORPHISM; ENZYME ACTIVITY; ESOPHAGUS CANCER; FOLATE METABOLISM; GENE MAPPING; HEAD AND NECK CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; PANCREAS CANCER; REVIEW; STOMACH CANCER; UROGENITAL TRACT CANCER;

EID: 84871340453     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2101-2     Document Type: Review

References (181)

1. Schwann B, Rozen R (2001) Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenomics 1(3):189-201
2. Goyette P, Pai A, Milos R et al (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9(8):571-582
3. Goyette P, Rozen R (2000) The thermolabile variant 677C→T can further reduce activity when expressed in cis with severe mutations for human methylenetetrahydrofolate reductase. Hum Mutat 16(2):132-138
4. Robien K, Ulrich CM (2003) 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157(7):571-582
5. Yang QH, Botto LD, Gallagher M et al (2008) Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 88(1):232-246
6. Boushey CJ, Beresford SA, Omenn GS et al (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274(13):1049-1057
7. Ueland PM, Refsum H, Stabler SP et al (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39(9):1764-1779
8. Sazci A, Ergül E, Güzelhan Y et al (2003) Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res Mol Brain Res 117(1):104-107
9. Kupferminc MJ, Eldor A, Steinman N et al (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340(1):9-13
10. Mills JL, Kirke PN, Molloy AM et al (1999) Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 86(1):71-74
11. Wenstrom KD, Johanning GL, Johnston KE et al (2001) Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 184(5):806-812
12. Qiu LX, Zhang J, Li WH et al (2011) Lack of association between methlenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility. Mol Biol Rep 38(4):2295-2299
13. Mohammad NS, Yedluri R, Addepalli P et al (2011) Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem 349(1-2):159-167
14. Huang MY, Wang YH, Chen FM et al (2008) Multiple genetic polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC highly correlated with early relapse of breast cancer patients in Taiwan. Ann Surg Oncol 15(3):872-880
15. Alshatwi AA (2010) Breast cancer risk, dietary intake and methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphisms. Food Chem Toxicol 48(7):1881-1885
16. Perel'muter VM, Zav'ialova MV, Vtorushin SV et al (2008) Genetic and clinical and pathological characteristics of breast cancer in premenopausal and postmenopausal women. Adv Gerontol 21(4):643-653
17. Suzuki T, Matsuo K, Hirose K et al (2008) One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29(2):356-362
18. Maruti SS, Ulrich CM, Jupe ER et al (2009) MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 11(6):R91
19. Ericson UC, Ivarsson MI, Sonestedt E et al (2009) Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr 90(5):1380-1389
20. Batschauer AP, Cruz NG, Oliveira VC et al (2011) HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women. Mol Cell Biochem 357(1-2):247-253
21. Prasad VV, Wilkhoo H (2011) Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian and cervical cancers. Onkologie 34(8-9):422-426
22. Eroglu A, Karabıyık A, Akar N (2012) The association of protease activated receptor 1 gene -506 I/D polymorphism with disease-free survival in breast cancer patients. Ann Surg Oncol 19(4):1365-1369
23. Ziva Cerne J, Stegel V, Gersak K et al (2011) Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk. Mol Med Report 4(1):175-179
24. Knechtel G, Hofmann G, Gerger A et al (2010) Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol 136(12):1813-1819
25. Xu X, Gammon MD, Wetmur JG et al (2008) B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev 17(8):2109-2116
26. Lewis SJ, Harbord RM, Harris R et al (2006) Meta-analyses of observational and genetic association studies of folate intakes or levels and breastcancer risk. J Natl Cancer Inst 98(22):1607-1622
27. Hekim N, Ergen A, Yaylim I et al (2007) No association between methylenetetrahydrofolatereductase C677T polymorphism and breast cancer. Cell Biochem Funct 25(1):115-117
28. Yu CP, Wu MH, Chou YC et al (2007) Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Anticancer Res 27(3B):1727-1732
29. Sangrajrang S, Sato Y, Sakamoto H et al (2010) Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat 123(3):885-893
30. Tao MH, Shields PG, Nie J et al (2009) DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol Biomarkers Prev 18(3):998-1002
31. Martin YN, Olson JE, Ingle JN et al (2006) Methylenetetrahydrofolate reductasehaplotype tag single-nucleotide polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(11):2322-2324
32. Vaner AS, Boiarskikh UA, Voronina EN et al (2010) Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk ofbreastcancer in West Siberian Region of Russia. Mol Biol 44(5):816-823
33. Ma E, Iwasaki M, Kobayashi M et al (2009) Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk ofbreastcancer: a case-control study in Japan. Nutr Cancer 61(4):447-456
34. Ferroni P, Palmirotta R, Martini F et al (2009) Determinants of homocysteine levels in colorectal andbreastcancer patients. Anticancer Res 29(10):4131-4138
35. Beetstra S, Suthers G, Dhillon V et al (2008) Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer. Cancer Epidemiol Biomarkers Prev 17(10):2565-2571
36. Kotsopoulos J, Zhang WW, Zhang S et al (2008) Polymorphisms in folate metabolizing enzymes and transport proteins and the risk ofbreast cancer. Breast Cancer Res Treat 112(3):585-593
37. Mir MM, Dar JA, Dar NA et al (2008) Combined impact of polymorphism of folate metabolism genes; glutamate carboxypeptidase, methylene tetrahydrofolate reductase and methionine synthase reductase on breast cancer susceptibility in Kashmiri women. Int J Health Sci 2(1):3-14
38. Guillem VM, Collado M, Terol MJ et al (2007) Role ofMTHFR(677, 1298) haplotype in the risk of devoloping secondary leukemia after treatment ofbreastcancer and hematological malignancies. Leukemia 21(7):1413-1422
39. Martin DN, Boersma BJ, Howe TM et al (2006) Association ofMTHFRgene polymorphisms withbreastcancer survival. BMC Cancer 6:257
40. Jakubowska A, Gronwald J, Menkiszak J et al (2007) Methylenetetrahydrofolatereductasepolymorphisms modify BRCA1-associatedbreastand ovarian cancer risks. Breast Cancer Res Treat 104(3):299-308
41. Chou YC, Wu MH, Yu JC et al (2006) Genetic polymorphisms of themethylenetetrahydrofolatereductasegene, plasma folate levels andbreastcancer susceptibility: a case-control study in Taiwan. Carcinogenesis 27(11):2295-2300
42. Stevens VL, McCullough ML, Pavluck AL et al (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausalbreast cancer incidence. Cancer Epidemiol Biomarkers Prev 16(6):1140-1147
43. Pepe C, Guidugli L, Sensi E et al (2007) Methyl group metabolism gene polymorphisms as modifier ofbreastcancer risk in Italian BRCA1/2 carriers. Breast Cancer Res Treat 103(1):29-36
44. Ericson U, Sonestedt E, Ivarsson MI et al (2009) Folate intake,methylenetetrahydrofolatereductasepolymorphisms, andbreastcancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 18(4):1101-1110
45. Gao CM, Tang JH, Cao HX et al (2009) MTHFRpolymorphisms, dietary folate intake andbreastcancer risk in Chinese women. J Hum Genet 54(7):414-418
46. Papandreou CN, Doxani C, Zdoukopoulos N et al (2012) Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate gene-association study in a South-eastern European population. DNA Cell Biol 31(2):193-198
47. Kwak SY, Kim UK, Cho HJ et al (2008) Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res 28(5A):2807-2811
48. Cui LH, Song Y, Si H et al (2011) Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China. Med Oncol. doi: 10.1007/s12032-011-0066-y
49. Mu LN, Cao W, Zhang ZF et al (2007) Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control 18(6):665-675
50. Zhu ZZ, Cong WM, Liu SF et al (2006) A study on the association ofMTHFRC677T polymorphism with genetic susceptibility to hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 14(3):196-198
51. Suzuki T, Matsuo K, Sawaki A et al (2008) Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 17(10):2742-2747
52. Nisevic I, Dinic J, Nikolic A et al (2008) MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma. Cell Biochem Funct 26(6):659-663
53. Wang L, Lin DX, Lu XH et al (2006) Study on the relations between genetic polymorphisms in methylenetetrahydrofolate reductase, methionine synthase and the risk of pancreatic cancer. Zhonghua Liu Xing Bing Xue Za Zhi 27(1):50-54
54. Qin JM, Wang XM, Chen B et al (2008) Study on the ingestion of folate and polymorphism ofMTHFRC677T with esophageal cancer in Xinjiang Kazakh. Zhonghua Liu Xing Bing Xue Za Zhi 29(1):30-33
55. Liu YX, Wang B, Wan MH et al (2011) Meta-analysis of the relationship between the methylenetetrahydrofolatereductaseC677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev 12(1):247-252
56. Qin JM, Yang L, Chen B et al (2008) Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P450E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol 14(45):6986-6992
57. Li D, Diao Y, Li H et al (2008) Association of the polymorphisms ofMTHFRC677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma. Arch Med Res 39(6):594-600
58. Umar M, Upadhyay R, Khurana R et al (2010) Evaluation of MTHFR 677C>T polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: a case-control study in a northern Indian population. Nutr Cancer 62(6):743-749
59. Lu C, Xie H, Wang F et al (2011) Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer 11:91
60. Zeybek U, Yaylim I, Yilmaz H et al (2007) MethylenetetrahydrofolatereductaseC677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct 25(4):419-422
61. Boccia S, Gianfagna F, Persiani R et al (2007) MethylenetetrahydrofolatereductaseC677T and A1298C polymorphisms and susceptibility to gastricadenocarcinoma in an Italian population. Biomarkers 12(6):635-644
62. Li S, Ji M, He N et al (2007) Application of microarray-based method for methylenetetrahydrofolate reductase (MTHFR) polymorphisms in the risk of gastric carcinoma in east China population. J Nanosci Nanotechnol 7(9):3245-3249
63. Mu LN, Cao W, Zhang ZF et al (2007) Polymorphisms of 5,10- methylenetetrahydrofolatereductase(MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers 12(1):61-75
64. Zhang FF, Terry MB, Hou L et al (2007) Genetic polymorphisms in folate metabolism and the risk ofstomachcancer. Cancer Epidemiol Biomarkers Prev 16(1):115-121
65. Neves Filho EH, Alves MK, Lima VP et al (2010) MTHFR C677T polymorphism and differential methylation status in gastric cancer: an association with Helicobacter pylori infection. Virchows Arch 457(6):627-633
66. Götze T, Röcken C, Röhl FW et al (2007) Gene polymorphisms of folate metabolizing enzymes and the risk ofgastriccancer. Cancer Lett 251(2):228-236
67. Zúñiga-Noriega JR, Velazco-Campos Mdel R, Aguirre-Rodríguez A et al (2007) C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex 72(4):355-358
68. DeRe V, Cannizzaro R, Canzonieri V et al (2010) MTHFRpolymorphisms ingastriccancer and in first-degree relatives of patients withgastric cancer. Tumour Biol 31(1):23-32
69. Lin D, Li H, Tan W et al (2007) Genetic polymorphisms in folate-metabolizing enzymes and risk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer development. Forum Nutr 60:140-145
70. Wang L, Ke Q, Chen W et al (2007) Polymorphisms of MTHFD, plasma homocysteine levels, and risk ofgastriccancer in a high-risk Chinese population. Clin Cancer Res 13(8):2526-2532
71. Cui LH, Shin MH, Kweon SS et al (2010) MethylenetetrahydrofolatereductaseC677T polymorphism in patients withgastricand colorectal cancer in a Korean population. BMC Cancer 10:236
72. Wang Y, Guo W, He Y et al (2007) Association ofMTHFRC677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control 18(2):143-152
73. Ko KH, Kim NK, Yim DJ et al (2006) Polymorphisms of 5,10- methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population. Anticancer Res 26(6B):4229-4233
74. Graziano F, Kawakami K, Ruzzo A et al (2006) Methylenetetrahydrofolatereductase677C/T gene polymorphism,gastriccancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer 118(3):628-632
75. Lacasaña-Navarro M, Galván-Portillo M, Chen J et al (2006) Methylenetetrahydrofolatereductase677C>T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer 42(4):528-533
76. Promthet SS, Pientong C, Ekalaksananan T et al (2010) Risk factors forcolon cancerin Northeastern Thailand: interaction ofMTHFRcodon 677 and 1298 genotypes with environmental factors. J Epidemiol 20(4):329-338
77. Haghighi MM, Radpour R, Mahmoudi T et al (2009) Associaiton between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer. Oncol Res 18(2-3):57-63
78. Levine AJ, Figueiredo JC, Lee W et al (2010) Geneticvariability in theMTHFRgene and colorectalcancerrisk using the colorectalcancer family registry. Cancer Epidemiol Biomarkers Prev 19(1):89-100
79. El Awady MK, Karim AM, Hanna LS et al (2009) Methylenetetrahydrofolatereductasegene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals. Cancer Biomark 5(6):233-240
80. Osian G, Procopciuc L, Vlad L (2007) MTHFRpolymorphisms as prognostic factors in sporadic colorectalcancer. J Gastrointestin Liver Dis 16(3):251-256
81. Chang SC, Lin PC, Lin JK et al (2007) Role ofMTHFRpolymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis 22(5):483-489
82. Cao HX, Gao CM, Takezaki T et al (2008) Geneticpolymorphisms ofmethylenetetrahydrofolatereductaseand susceptibility to colorectal cancer. Asian Pac J Cancer Prev 9(2):203-208
83. Wang J, Gajalakshmi V, Jiang J et al (2006) 5,10- methylenetetrahydrofolatereductasecodon 677 and 1298genetic polymorphisms and environmental factors with reference to susceptibility to colorectalcancer: a case-control study in an Indian population. Int J Cancer 118(4):991-997
84. Iacopetta B, Heyworth J, Girschik J et al (2009) TheMTHFRC677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectalcancer. Int J Cancer 125(1):84-90
85. Komlosi V, Hitre E, Pap E et al (2010) SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer. BMC Cancer 10:525
86. Derwinger K, Wettergren Y, Odin E et al (2009) A study of the MTHFR genepolymorphismC677T in colorectalcancer. Clin Colorectal Cancer 8(1):43-48
87. Rodrigues JO, Galbiatti AL, Ruiz MT et al (2010) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene and risk of head and neck squamous cell carcinoma. Braz J Otorhinolaryngol 76(6):776-782
88. Fard-Esfahani P, Fard-Esfahani A, Saidi P et al (2011) An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygouspolymorphismin theMTHFR Gene. Cancer Epidemiol 35(1):56-58
89. Supic G, Jovic N, Kozomara R et al (2011) Interaction between theMTHFRC677T polymorphism and alcohol-impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res 90(1):65-70
90. Solomon PR, Selvam GS, Shanmugam G (2008) Polymorphism in ADH andMTHFRgenes in oral squamous cell carcinoma of Indians. Oral Dis 14(7):633-639
91. Suzuki T, Matsuo K, Hasegawa Y et al (2007) One-carbon metabolism-related gene polymorphisms and risk ofheadand neck squamous cell carcinoma: case-control study. Cancer Sci 98(9):1439-1446
92. Vairaktaris E, Yapijakis C, Kessler P et al (2006) Methylenetetrahydrofolatereductasepolymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132(4):219-222
93. Sailasree R, Nalinakumari KR, Sebastian P et al (2011) Influence of methylenetetrahydrofolate reductase polymorphisms in oral cancer patients. J Oral Pathol Med 40(1):61-66
94. Tsai CW, Hsu CF, Tsai MH et al (2011) Methylenetetrahydrofolate reductase (MTHFR) genotype, smoking habit, metastasis and oral cancer in Taiwan. Anticancer Res 31(6):2395-2399
95. Boccia S, Boffetta P, Brennan P et al (2009) Meta-analyses of themethylenetetrahydrofolatereductaseC677T and A1298C polymorphisms and risk ofheadand neck and lung cancer. Cancer Lett 273(1):55-61
96. Galbiatti AL, Ruiz MT, Rodrigues JO et al (2012) Polymorphisms and haplotypes inmethylenetetrahydrofolatereductasegene andheadand neck squamous cell carcinoma risk. Mol Biol Rep 39(1):635-643
97. Cao Y, Miao XP, Huang MY et al (2010) Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from southern China. Mol Carcinog 49(11):928-934
98. Ni X, Tai J, Ma LJ et al (2008) Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of laryngeal squamous cell carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 43(6):435-438
99. Kruszyna Ł, Lianeri M, Rydzanicz M et al (2010) Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep 37(1):241-247
100. Siraj AK, Ibrahim M, Al-Rasheed M et al (2008) Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. BMC Med Genet 9:61
101. Liu CS, Tsai CW, Hsia TC et al (2009) Interaction ofmethylenetetrahydrofolatereductasegenotype and smoking habit in Taiwaneselung cancerpatients. Cancer Genomics Proteomics 6(6):325-329
102. Arslan S, Karadayi S, Yildirim ME et al (2011) The association between methylenetetrahydrofolatereductasegene polymorphism andlung cancerrisk. Mol Biol Rep 38(2):991-996
103. Liu H, Jin G, Wang H et al (2008) Association of polymorphisms in one-carbon metabolizing genes andlung cancerrisk: a case-control study in Chinese population. Lung Cancer 61(1):21-29
104. Suzuki T, Matsuo K, Hiraki A et al (2007) Impact of one-carbon metabolism-related gene polymorphisms on risk oflung cancerin Japan: a case control study. Carcinogenesis 28(8):1718-1725
105. Kiyohara C, Horiuchi T, Takayama K et al (2011) Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese Population. BMC Cancer 11:459
106. Matakidou A, El Galta R, Rudd MF et al (2007) Prognostic significance of folate metabolism polymorphisms forlung cancer. Br J Cancer 97(2):247-252
107. Hung RJ, Hashibe M, McKay J et al (2007) Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis 28(6):1334-1340
108. Cui LH, Shin MH, Kim HN et al (2011) MethylenetetrahydrofolatereductaseC677T polymorphism in patients withlung cancerin a Korean population. BMC Med Genet 12:28
109. Gemignani F, Landi S, Szeszenia-Dabrowska N et al (2007) Development oflung cancerbefore the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28(6):1287-1293
110. Ruiz-Argüelles GJ, Coconi-Linares LN, Garcés-Eisele J et al (2007) Methotrexate-induced mucositis in acuteleukemiapatients is not associated with theMTHFR 677T allele in Mexico. Hematology 12(5):387-391
111. Giovannetti E, Ugrasena DG, Supriyadi E et al (2008) Methylenetetrahydrofolatereductase(MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and withoutleukemia. Leuk Res 32(1):19-24
112. Tong N, Fang Y, Li J et al (2010) Methylenetetrahydrofolatereductase polymorphisms, serum methylenetetrahydrofolatereductase levels, and risk of childhood acute lymphoblasticleukemiain a Chinese population. Cancer Sci 101(3):782-786
113. Pietrzyk JJ, Bik-Multanowski M, Balwierz W et al (2009) Additional genetic risk factor for death in children with acute lymphoblasticleukemia: a common polymorphism of theMTHFRgene. Pediatr Blood Cancer 52(3):364-368
114. Alcasabas P, Ravindranath Y, Goyette G et al (2008) 5,10- methylenetetrahydrofolatereductase(MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer 51(2):178-182
115. Kim HN, Kim YK, Lee IK et al (2009) Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leuk Res 33(1):82-87
116. Imanishi H, Okamura N, Yagi M et al (2007) Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblasticleukemiaand malignant lymphoma. J Hum Genet 52(2):166-171
117. Chen BA, Jiang N, Ji MJ et al (2006) A new method for 5,10-methylenetetrahydrofolatereductasesingle nucleotide polymorphisms genotyping used to study susceptibility of hematological malignancy. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14(6):1069-1077
118. Bolufer P, Barragan E, Collado M et al (2006) Influence of genetic polymorphisms on the risk of developingleukemiaand on disease progression. Leuk Res 30(12):1471-1491
119. Robien K, Bigler J, Yasui Y et al (2006) Methylenetetrahydrofolatereductaseand thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenousleukemia. Biol Blood Marrow Transplant 12(9):973-980
120. Zanrasso CW, Hatagima A, Emerenciano M et al (2006) The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 30(4):477-481
121. Reddy H, Jamil K (2006) Polymorphisms in theMTHFRgene and their possible association with susceptibility to childhood acute lymphocyticleukemiain an Indian population. Leuk Lymphoma 47(7):1333-1339
122. Koppen IJ, Hermans FJ, Kaspers GJ (2010) Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 148(1):3-14
123. Krull KR, Brouwers P, Jain N et al (2008) Folate pathway genetic polymorphisms are related to attention disorders in childhoodleukemia survivors. J Pediatr 152(1):101-105
124. Thomas P, Fenech M (2008) Methylenetetrahydrofolatereductase, common polymorphisms, and relation to disease. Vitam Horm 79:375-392
125. Zintzaras E, Koufakis T, Ziakas PD et al (2006) A meta-analysis of genotypes and haplotypes ofmethylenetetrahydrofolatereductasegene polymorphisms in acute lymphoblasticleukemia. Eur J Epidemiol 21(7):501-510
126. Yang L, Liu L, Wang J et al (2011) Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leuk Lymphoma 52(9):1770-1776
127. Damnjanovic T, Milicevic R, Novkovic T et al (2010) Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children. J Pediatr Hematol Oncol 32(4):148-150
128. Tantawy AA, El-Bostany EA, Adly AA et al (2010) Methylene tetrahydrofolatereductasegene polymorphism in Egyptian children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis 21(1):28-34
129. Pereira TV, Rudnicki M, Pereira AC et al (2006) Do polymorphisms of 5,10-methylenetetrahydrofolatereductase(MTHFR) gene affect the risk of childhood acute lymphoblasticleukemia? Eur J Epidemiol 21(12):885-886
130. Sood S, Das R, Trehan A et al (2010) Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians. Leuk Lymphoma 51(5):928-932
131. de Jonge R, Tissing WJ, Hooijberg JH et al (2009) Polymorphisms in folate-related genes and risk of pediatric acute lymphoblasticleukemia. Blood 113(10):2284-2289
132. Yan J, Yin M, Dreyer ZE et al (2012) A meta-analysis ofMTHFRC677T and A1298C polymorphisms and risk of acute lymphoblastic leukemiain children. Pediatr Blood Cancer 58(4):513-518
133. Benetatos L, Dasoula A, Hatzimichael E et al (2011) Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloidleukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Ann Hematol 90(9):1037-1045
134. Karathananis NV, Stiakaki E, Goulielmos GN et al (2011) The role of the methylenetetrahydrofolatereductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia. Genet Test Mol Biomarkers 15(1-2):5-10
135. Sadananda Adiga MN, Chandy S, Ramachandra N et al (2010) Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemiain children. Indian J Cancer 47(1):40-45
136. Kamel AM, Moussa HS, Ebid GT et al (2007) Synergistic effect of methyltetrahydrofolatereductase(MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblasticleukemia. J Egypt Natl Canc Inst 19(2):96-105
137. Oh D, Kim NK, Jang MJ et al (2007) Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia. Anticancer Res 27(5A):3419-3424
138. Amorim MR, Zanrosso CW, Magalhaes IQ et al (2008) MTHFR677C→T and 1298A→C polymorphisms in children with Down syndrome and acute myeloidleukemiain Brazil. Pediatr Hematol Oncol 25(8):744-750
139. Kim NK, Chong SY, Jang MJ et al (2006) Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res 26(4B):2879-2881
140. Lv L, Wu C, Sun H et al (2010) Combined 677CC/1298AC genotypes ofmethylenetetrahydrofolatereductase(MTHFR) reduce susceptibility to precursor B lymphoblasticleukemiain a Chinese population. Eur J Haematol 84(6):506-512
141. Moon HW, Kim TY, Oh BR et al (2007) MTHFR677CC/1298CC genotypes are highly associated with chronic myelogenousleukemia: a case-control study in Korea. Leuk Res 31(9):1213-1217
142. Hur M, Park JY, Cho HC et al (2006) MethylenetetrahydrofolatereductaseA1298C genotypes are associated with the risks of acute lymphoblasticleukaemiaand chronic myelogenousleukaemiain the Korean population. Clin Lab Haematol 28(3):154-159
143. Azhar MR, Rahimi Z, Vaisi-Raygani A et al (2012) Lack of associaiton between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish Population from Western Iran. Genet Test Mol Biomarkers 16(3):198-202
144. Lee KM, Lan Q, Kricker A et al (2007) One-carbon metabolism gene polymorphisms and risk of non-Hodgkinlymphomain Australia. Hum Genet 122(5):525-533
145. Seidemann K, Book M, Zimmermann M et al (2006) MTHFR677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. Ann Hematol 85(5):291-300
146. Kurzwelly D, Knop S, Guenther M et al (2010) Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. J Neurooncol 100(2):187-192
147. Ismail SI, Ababneh NA, Khader Y et al (2009) Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma. Cancer Genet Cytogenet 195(2):120-124
148. Kim HN, Lee IK, Kim YK et al (2008) Association between folate-metabolizing pathway polymorphism and non-Hodgkinlymphoma. Br J Haematol 140(3):287-294
149. Kasperzyk JL, Chang ET, Birmann BM et al (2011) Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study. Am J Epidemiol 174(7):816-827
150. da Costa DM, de Lima GP, Faria MH et al (2012) Polymorphisms of folate pathway enzymes (methylenetetrahydrofolatereductaseand thymidylate synthase) and
151. Bethke L, Webb E, Murray A et al (2008) Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17(5):1195-1202
152. Sirachainan N, Wongruangsri S, Kajanachumpol S et al (2008) Folate pathwaygeneticpolymorphisms and susceptibility of central nervous system tumors in Thai children. Cancer Detect Prev 32(1):72-78
153. Kafadar AM, Yilmaz H, Kafadar D et al (2006) C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas. Anticancer Res 26(3B):2445-2449
154. Shekari M, Sobti RC, Kordi Tamandani DM et al (2008) Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 278(6):517-524
155. Tong SY, Kim MK, Lee JK et al (2011) Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12. Cancer Causes Control 22(1):63-77
156. Kohaar I, Kumar J, Thakur N et al (2010) Homocysteine levels are associated with cervicalcancerindependent of methylenetetrahydrofolatereductasegene (MTHFR) polymorphisms in Indian population. Biomarkers 15(1):61-68
157. Uvuz F, Kilic S, Yilmaz N et al (2009) Relationship between preterm labor and thrombophilic gene polymorphism: a prospective sequential cohort study. Gynecol Obstet Invest 68(4):234-238
158. Tong SY, Lee JM, Song ES et al (2010) The effects of polymorphisms inmethylenetetrahydrofolatereductase(MTHFR), methionine synthase (MTR), and methionine synthasereductase(MTRR) on the risk of cervical intraepithelial neoplasia and cervicalcancerin Korean women. Cancer Causes Control 21(1):23-30
159. Xu WH, Shrubsole MJ, Xiang YB et al (2007) Dietary folate intake,MTHFRgeneticpolymorphisms, and the risk of endometrialcanceramong Chinese women. Cancer Epidemiol Biomarkers Prev 16(2):281-287
160. Delgado-Enciso I, Martínez-Garza SG, Rojas-Martínez A et al (2006) The effect ofMTHFRpolymorphisms, pregnancy and first intercourse on cervicalcancerin a population from the Northeastern Mexico. Rev Invest Clin 58(5):462-469
161. Piyathilake CJ, Azrad M, Macaluso M et al (2007) Protective association ofMTHFRpolymorphismon cervical intraepithelial neoplasia is modified by riboflavin status. Nutrition 23(3):229-235
162. Rao GG, Kurien A, Gossett D et al (2006) A case-control study of methylenetetrahydrofolatereductase polymorphisms in cervical carcinogenesis. Gynecol Oncol 101(2):250-254
163. Nandan NK, Wajid S, Biswas S et al (2008) Allelic variations in 5,10-methylenetetrahydrofolatereductasegene and susceptibility to cervicalcancerin Indian women. Drug Metab Lett 2(1):18-22
164. Johansson M, Van Guelpen B, Hultdin J et al (2007) TheMTHFR677C→T polymorphism and risk ofprostatecancer: results from the CAPS study. Cancer Causes Control 18(10):1169-1174
165. Wu HC, Chang CH, Tsai RY et al (2010) Significant association of methylenetetrahydrofolate reductasesingle nucleotide polymorphisms with prostate cancer susceptibility in Taiwan. Anticancer Res 30(9):3573-3577
166. Marchal C, Redondo M, Reyes-Engel A et al (2008) Association between polymorphisms of folate-metabolizing enzymes and risk ofprostatecancer. Eur J Surg Oncol 34(7):805-810
167. Safarinejad MR, Shafiei N, Safarinejad S (2010) Relationship between three polymorphisms ofmethylenetetrahydrofolatereductase(MTHFR C677T, A1298C, and G1793A) gene and risk ofprostatecancer: a case-control study. Prostate 70(15):1645-1657
168. Van Guelpen BR, Wirén SM, Bergh AR et al (2006) Polymorphisms ofmethylenetetrahydrofolatereductaseand the risk ofprostatecancer: a nested case-control study. Eur J Cancer Prev 15(1):46-50
169. Cai DW, Liu XF, Bu RG et al (2009) Geneticpolymorphisms ofMTHFRand aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population. J Int Med Res 37(6):1882-1889
170. Muslumanoglu MH, Tepeli E, Demir S et al (2009) The analysis of the relationship between A1298C and C677T polymorphisms of theMTHFRgene withprostatecancer in Eskisehir population. Genet Test Mol Biomarkers 13(5):641-645
171. Chung CJ, Pu YS, Su CT et al (2010) Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma. Cancer Causes Control 21(10):1605-1613
172. Manuguerra M, Matullo G, Veglia F et al (2007) Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carsinogenesis 28(2):414-422
173. Rouissi K, Ouerhani S, Oliveira E et al (2009) Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunusian population. Cancer Genet Cytogenet 195(1):43-45
174. Safarinejad MR, Shafiei N, Safarinejad S (2011) Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men. Med Oncol. doi: 10.1007/s12032-010-9723-9
175. Moore LE, Malats N, Rothman N et al (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120(11):2452-2458
176. Sanyal S, Ryk C, De Verdier PJ et al (2007) Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms. Scand J Urol Nephrol 41(3):182-190
177. Izmirli M, Inandiklioglu N, Abat D et al (2011) Polymorphisms of MTHFR gene on bladder cancer in Turkish Population. Asian Pac J Cancer Prev 12(7):1833-1835
178. Safarinejad MR, Shafiei N, Safarinejad S (2012) Methlenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cellrenalcell carcinoma and tumour behaviour in men. Clin Oncol 24(4):269-281
179. Sakano S, Hinoda Y, Okayama N et al (2010) Gender-specific association ofmethylenetetrahydrofolatereductasegenotype and haplotype with the aggressiveness and prognosis of clear cellrenalcell carcinoma in Japanese patients. BJU Int 106(3):424-430
180. Ferrara M, Capozzi L, Russo R (2009) Impact of theMTHFRC677T polymorphism on risk of Wilms tumor: case-control study. J Pediatr Hematol Oncol 31(4):256-258
181. Moore LE, Hung R, Karami S et al (2008) Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 122(8):1710-1715